Scientists investigate mysterious genetic variants behind rare inflammatory diseases

NCT ID NCT06354322

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at people with autoinflammatory diseases or AA amyloidosis who have genetic changes that are hard to interpret. Researchers want to understand if these changes actually cause the disease. The goal is to improve diagnosis and knowledge, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help doctors interpret unclear genetic test results, leading to better diagnosis of autoinflammatory diseases.
What could go wrong: This is an observational study, not a treatment trial. It may not directly benefit participants, and the findings might not change current care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AA AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AA amyloidosis autoinflammatory syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AA AMYLOIDOSIS AUTOINFLAMMATORY DISEASE

Contacts and locations

Locations

Service médecine interne-Hôpital Tenon
RECRUITING

Paris, 75020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.